国产一区一二区高清不卡,国产一区二区最新免费视频,51日日夜夜精品视频,日日夜夜精品视频天天7799,五月伊人国语,国产一区视频,7777无码少妇一区二区三区,五月伊人国语,7799精彩视频天天看网站,国产精品无码久久久久av,永久入口,91成品人网页进入入口,欧美 日韩 中文字幕 高清,妖精视频一区二区三区亚洲,精品亚洲永久免费精品导航,久久久国产一区二区三区,天天中文综合

The approximate number of days to obtain FDA certification in the United States varies based on the type of product and regulatory pathway. Here’s a general breakdown:

1. Medical Devices:

   • 510(k) Notification: The review process typically takes about 90 days. However, this can extend if additional information or clarification is needed from the applicant. Total processing time, including preparation and potential follow-ups, may range from 3 to 6 months.
   • Premarket Approval (PMA): Generally, the PMA process takes between 180 and 360 days. This includes the time required for FDA review, which may be extended if the FDA requests additional data or if there are significant questions about the submission. Overall, from submission to approval, the process might take up to a year or more.
   • De Novo Classification: The review period for a De Novo request is usually around 120 days. As with other submissions, this timeframe can be extended depending on the complexity of the device and the completeness of the information provided.

2. Drugs:

   • New Drug Application (NDA): The standard review time is approximately 10 months. For drugs that receive priority review, this can be reduced to about 6 months. The total time from initial submission to approval may be around 6 to 12 months, considering potential interactions with the FDA.
   • Abbreviated New Drug Application (ANDA): The review process for generic drugs typically takes around 10 months. This timeline can vary based on the completeness of the submission and any additional FDA queries.

3. Biologics:

   • Biologics License Application (BLA): The standard review time is about 10 months. If the application qualifies for priority review, this can be reduced to approximately 6 months. The entire process, including preparation and FDA interactions, might span from 6 to 12 months.

4. Food Products:

   • Generally Recognized as Safe (GRAS) Notification: The review period can vary significantly, typically taking several months to a year. This depends on the complexity of the safety data provided and the FDA’s evaluation process.

Overall, while the FDA's review times provide a general guideline, actual processing times can be influenced by the completeness of the submission, the need for additional information, and the FDA's current workload.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn